Genentech: Die Anfänge der Biotechnologie [Synthese] - Hughes, Sally Smith - gut-

Ursprünglicher Text
Genentech: The Beginnings of Biotech [Synthesis] - Hughes, Sally Smith - Good
uncommonly
(2213)
Angemeldet als privater Verkäufer
Verbraucherschützende Vorschriften, die sich aus dem EU-Verbraucherrecht ergeben, finden daher keine Anwendung. Der eBay-Käuferschutz gilt dennoch für die meisten Käufe.
US $3,08
Ca.EUR 2,66
oder Preisvorschlag
Bisher US $3,50 (- 12%)Was bedeutet dieser Preis?
Aktueller Verkaufspreis (Angabe des Verkäufers)
Artikelzustand:
Sehr gut
Sonderaktion endet in: 4 T 4 Std
Schnell, bevor er weg ist. 1 Person beobachtet diesen Artikel.
Abholung:
Kostenlose Abholung in Long Beach, New York, USA.
Versand:
US $4,47 (ca. EUR 3,86) USPS Media MailTM.
Standort: Long Beach, New York, USA
Lieferung:
Lieferung zwischen Sa, 18. Okt und Fr, 24. Okt nach 94104 bei heutigem Zahlungseingang
Wir wenden ein spezielles Verfahren zur Einschätzung des Liefertermins an – in diese Schätzung fließen Faktoren wie die Entfernung des Käufers zum Artikelstandort, der gewählte Versandservice, die bisher versandten Artikel des Verkäufers und weitere ein. Insbesondere während saisonaler Spitzenzeiten können die Lieferzeiten abweichen.
Rücknahme:
Keine Rücknahme.
Zahlungen:
    Diners Club

Sicher einkaufen

eBay-Käuferschutz
Geld zurück, wenn etwas mit diesem Artikel nicht stimmt. Mehr erfahreneBay-Käuferschutz - wird in neuem Fenster oder Tab geöffnet
Der Verkäufer ist für dieses Angebot verantwortlich.
eBay-Artikelnr.:256864880534

Artikelmerkmale

Artikelzustand
Sehr gut: Buch, das nicht neu aussieht und gelesen wurde, sich aber in einem hervorragenden Zustand ...
ISBN
9780226045511
Kategorie

Über dieses Produkt

Product Identifiers

Publisher
University of Chicago Press
ISBN-10
022604551X
ISBN-13
9780226045511
eBay Product ID (ePID)
28038271795

Product Key Features

Book Title
Genentech : the Beginnings of Biotech
Number of Pages
232 Pages
Language
English
Publication Year
2013
Topic
Biotechnology, Industries / General, History, Corporate & Business History
Genre
Science, Business & Economics
Author
Sally Smith Hughes
Book Series
Synthesis Ser.
Format
Trade Paperback

Dimensions

Item Height
0.5 in
Item Weight
11.8 Oz
Item Length
9 in
Item Width
6 in

Additional Product Features

Intended Audience
Trade
Dewey Edition
22
Reviews
Drawing extensively on oral histories, Hughes reveals the day-to-day hands-on roles of both the venture capitalists and the scientists, their eyes fixed at once on scientific triumphs and corporate riches, who brought Genentech to life. Hughes vividly recounts the tough-minded deals, buccaneering strategies, laboratory struggles, and relentless patent arrangements that not only made for Genentech's success but that pioneered the new biotechnology industry's operational model., Sally Smith Hughes's book on the formative years of Genentech helps fill a gaping hole in the history of biotechnology, as it grew out of the recombinant DNA technology in the 1970s and 1980s. This book covers the quake from its epicenter. It draws on two decades of research, thousands of conversations, hundreds of documents, and dozens of oral history interviews. This zippy read will be welcomed by those who care about the San Francisco Bay area, biotechnology, the history of molecular biology, and high-tech economic development. Genentech has long had its legends, statues, buildings, and view of Candlestick Park; now it has a book about its beginnings., [A]n eminently readable (and, for classes, eminently assignable) story . . . . Smith Hughes is one of the foremost oral historians of science today, and Genentech is filled with illuminating interview snippets woven artfully into a narrative that both engages and (somewhat surreptitiously) analyzes. . . . [F]or a case study that lays out in lively detail the ambiguities and exuberances of high-tech entrepreneurship, Smith Hughes's Genentech surely ranks among the very best., [A] fascinating book, vividly recount[ing] the blood, sweat, and tears of the early days of 'genetic engineers' working at the bench, designing new biomolecules, and capitalizing their promises on Wall Street., Sally Smith Hughes skillfully describes the improbable creation, difficult adolescence, immense prosperity, and eventual foundering of Genentech, the first biotech behemoth. It's a great tale, with a cast of fabulous characters and surprising episodes, ranging from Palo Alto to Wall Street. This is an outstanding book that should appeal to Nobel laureates as well as hedge-fund barons and ordinary citizens., My first job out of my postdoc was at Genentech in early 1981. At the time, I had no idea that all those guys in suits were doing something that had never been done before. But I did know the science was amazing--and Bob Swanson was the clear leader in creating an environment that supported that science. Sally Smith Hughes has brought to life the details of what the key players were up to--they weren't playing it safe, and they created a catalytic environment that generated a whole new industry., Sally Smith Hughes skillfully describes the improbable creation, difficult adolescence, immense prosperity, and eventual foundering of Genentech, the first biotech behemoth. It's a great tale, with a cast of fabulous characters and surprising episodes, ranging from Palo Alto to Wall Street. This is an outstanding book that should appeal to Nobel laureates as well as hedge-fund barons and ordinary citizens., Genentech: The Beginnings of Biotech paints a wonderfully detailed picture of an important beginning in the history of biotechnology., The author skillfully reveals the practical, day-to-day, hands-on roles played by venture capitalists focused on fiscal gain and scientists focused on scientific breakthroughs. . . . [A] fascinating read., My first job out of my postdoc was at Genentech in early 1981. At the time, I had no idea that all those guys in suits were doing something that had never been done before. But I did know the science was amazing-and Bob Swanson was the clear leader in creating an environment that supported that science. Sally Smith Hughes has brought to life the details of what the key players were up to-they weren't playing it safe, and they created a catalytic environment that generated a whole new industry., Hughes has crafted an engaging historical account of Genentech from its beginnings as a small laboratory at the University of California, San Francisco to the 2009 merger with Roche for 47 billion dollars. . . . [Her] account will appeal to a broad audience and is a must read for scholars interested in the history of biotechnology. Highly recommended., Hughes's Genentech makes an invaluable international contribution to understanding how a period just short of a decade redefined 'business as usual' for biologists., Over the past 20 years Sally Smith Hughes has done a great service to science studies by conducting in-depth oral-history interviews with prominent scientists, venture capitalists, corporate leaders, and attorneys in the history and business of early biotechnology. She drew on her unprecedented access to corporate records and a large number of actors and their oral histories to write Genentech , the first comprehensive account of the creation and early development of the Genentech Corporation.
Dewey Decimal
338.7/66060973
Table Of Content
Prologue Acknowledgments 1 / Inventing Recombinant DNA Technology Two Scientists on Converging Paths The Collaboration Patenting and Politics Steps toward Commercialization 2 / Creating Genentech Bob Swanson Founding Genentech Legal and Political Obstacles A Full Business Plan 3 / Proving the Technology A Portentous Experiment Switching Targets Negotiating Research Agreements Making Somatostatin Wider Issues 4 / Human Insulin: Genentech Makes its Mark Seeking Corporate Contracts Procuring a Facility and Staff Genentech''s Human Insulin Project The Eli Lilly Contract Publicity and Expansion 5 / Human Growth Hormone: Shaping a Commercial Future Competing for Human Growth Hormone Moving toward Corporate Integration Scaling Up Insulin and Growth Hormone Corporate Expansion An Emerging Culture 6 / Wall Street Debut Biomania Exit Strategies Interferon: The New Wonder Drug? Run-up to an Initial Public Offering Legal Impediments The IPO Epilogue Notes Bibliography Oral History Bibliography Index
Synopsis
In the fall of 1980, Genentech, Inc., a little-known California genetic engineering company, became the overnight darling of Wall Street, raising over $38 million in its initial public stock offering. Lacking marketed products or substantial profit, the firm nonetheless saw its share price escalate from $35 to $89 in the first few minutes of trading, at that point the largest gain in stock market history. Coming at a time of economic recession and declining technological competitiveness in the United States, the event provoked banner headlines and ignited a period of speculative frenzy over biotechnology as a revolutionary means for creating new and better kinds of pharmaceuticals, untold profit, and a possible solution to national economic malaise. Drawing from an unparalleled collection of interviews with early biotech players, Sally Smith Hughes offers the first book-length history of this pioneering company, depicting Genentech's improbable creation, precarious youth, and ascent to immense prosperity. Hughes provides intimate portraits of the people significant to Genentech's science and business, including cofounders Herbert Boyer and Robert Swanson, and in doing so sheds new light on how personality affects the growth of science. By placing Genentech's founders, followers, opponents, victims, and beneficiaries in context, Hughes also demonstrates how science interacts with commercial and legal interests and university research, and with government regulation, venture capital, and commercial profits. Integrating the scientific, the corporate, the contextual, and the personal, Genentech tells the story of biotechnology as it is not often told, as a risky and improbable entrepreneurial venture that had to overcome a number of powerful forces working against it.
LC Classification Number
HD9999.B444

Artikelbeschreibung des Verkäufers

Info zu diesem Verkäufer

uncommonly

97,6% positive Bewertungen3,8 Tsd. Artikel verkauft

Mitglied seit Dez 1998
Antwortet meist innerhalb 24 Stunden
Angemeldet als privater VerkäuferDaher finden verbraucherschützende Vorschriften, die sich aus dem EU-Verbraucherrecht ergeben, keine Anwendung. Der eBay-Käuferschutz gilt dennoch für die meisten Käufe.
uncommonly uncommon and common goods
Shop besuchenKontakt

Detaillierte Verkäuferbewertungen

Durchschnitt in den letzten 12 Monaten
Genaue Beschreibung
5.0
Angemessene Versandkosten
4.9
Lieferzeit
5.0
Kommunikation
5.0

Verkäuferbewertungen (1.865)

Alle Bewertungenselected
Positiv
Neutral
Negativ
  • c***r (20)- Bewertung vom Käufer.
    Letzte 6 Monate
    Bestätigter Kauf
    Used book as described, packed well for shipping and shipped promptly. Seller went the absolute distance in describing this used book. I particularly wanted this edition. From the photos and description of this item for sale, I was certain I would receive exactly what I was expecting and paid for. If I could give more than 5 Stars I would. Definitely would buy from this Seller again.
  • k***e (141)- Bewertung vom Käufer.
    Letzter Monat
    Bestätigter Kauf
    Wrapped well, came as described. Happy with my purchase.
  • b***l (1711)- Bewertung vom Käufer.
    Letzter Monat
    Bestätigter Kauf
    The Sunbeam mixer arrived today. You did such a great packing job that everything arrived safe and sound. The mixer is just like the one my cousin had that always said I should have been her child. She passed away in 2000. It proves to be of great value due to it still runs after all the years. Thanks.
    Antwort von flotsamundjetsam- Verkäufer flotsamundjetsam hat auf Bewertung reagiert.- Verkäufer flotsamundjetsam hat auf Bewertung reagiert.
    Thanks for the detailed feedback. I am glad you enjoy a quality made old school product that brings back great memories